Molecular docking analysis of triterpenoids from with breast cancer targets.
Ireen Christopher, Aishwariya Sounderraajan, Viji Murugesan, Indu Sabapathy, Vijayalakshmi Periyasamy, Rajalakshmi Manikkam
Author Information
Ireen Christopher: Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.
Aishwariya Sounderraajan: Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.
Viji Murugesan: Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.
Indu Sabapathy: Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.
Vijayalakshmi Periyasamy: Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.
Rajalakshmi Manikkam: Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.
中文译文
English
Breast cancer is a well-known complex disease. The availability of different screening approaches and booming phytochemical drug synthesis can contribute towards breast cancer treatment. Hence, we document the molecular docking analysis of triterpenoids from with breast cancer targets.
J Ocul Pharmacol Ther. 2022 Jan-Feb;38(1):43-55
[PMID: 34905402 ]
Breast Cancer (Auckl). 2018 May 30;12:1178223418774802
[PMID: 29899661 ]
Int J Clin Exp Pathol. 2015 Nov 01;8(11):14619-29
[PMID: 26823785 ]
Oncol Rev. 2022 Oct 03;16:10568
[PMID: 36531159 ]
Acta Pol Pharm. 2013 May-Jun;70(3):413-8
[PMID: 23757931 ]
Biomedicines. 2018 Feb 11;6(1):
[PMID: 29439457 ]
Ann Oncol. 2021 Oct;32(10):1256-1266
[PMID: 34384882 ]
J Nat Prod. 2010 Mar 26;73(3):500-16
[PMID: 20187635 ]
J Chromatogr A. 2012 Jun 1;1240:140-6
[PMID: 22525870 ]
Curr Med Chem. 2013;20(7):908-31
[PMID: 23210780 ]
Methods Mol Biol. 2015;1263:243-50
[PMID: 25618350 ]
BMC Complement Altern Med. 2013 Jan 31;13:26
[PMID: 23368430 ]
Molecules. 2013 Feb 27;18(3):2598-610
[PMID: 23446917 ]
J Med Chem. 2015 May 14;58(9):4066-72
[PMID: 25860834 ]
J Chromatogr A. 2012 Dec 14;1268:157-65
[PMID: 23141985 ]
Cell. 2012 Jun 8;149(6):1245-56
[PMID: 22682247 ]
J Sep Sci. 2018 Jan;41(1):6-19
[PMID: 28862795 ]
Curr Oncol Rep. 2019 Feb 26;21(3):25
[PMID: 30806829 ]
Nature. 2000 Oct 12;407(6805):770-6
[PMID: 11048727 ]
Nat Prod Rep. 2020 Sep 23;37(9):1207-1228
[PMID: 32368768 ]
Res Pharm Sci. 2018 Feb;13(1):57-64
[PMID: 29387112 ]
Pharmacognosy Res. 2015 Jul-Sep;7(3):217-24
[PMID: 26130932 ]
Br J Radiol. 2022 Feb 1;95(1130):20211033
[PMID: 34905391 ]
Crit Rev Biotechnol. 2019 Aug;39(5):618-632
[PMID: 31068012 ]
Mol Biol Cell. 2021 Nov 1;32(21):ar21
[PMID: 34406791 ]
J Ethnopharmacol. 2000 Sep;72(1-2):151-6
[PMID: 10967466 ]
J Adv Pharm Technol Res. 2012 Jan;3(1):1
[PMID: 22470885 ]
Nat Commun. 2020 Sep 11;11(1):4581
[PMID: 32917893 ]